In­dian health­care en­vi­ron­ment is gain­ing mo­men­tum

BioSpectrum (India) - - BIO CONTENT -

Ac­cord­ing to you, what are the trends in bio­sup­pli­ers market with re­spect to life sci­ences and health­care in­dus­try in In­dia?

With the ever evolv­ing re­quire­ments, ev­ery­body is seek­ing newer and bet­ter tech­nolo­gies that are eas­ier to use and are much more ac­cu­rate in per­form­ing mean­ing­ful and rel­e­vant re­search. For ex­am­ple: Ini­tially, BD be­gan with smaller num­ber of lasers in flow cy­tom­e­try tech­nol­ogy (1 laser, 2 laser, 3 laser) but now we have started us­ing up to ten lasers with 4 to 12 pa­ram­e­ters as the usual dis­cus­sion points, we now have ac­cess to up to 50 pa­ram­e­ters. We can now study up to 50 dif­fer­ent char­ac­ter­is­tics of a sin­gle cell si­mul­ta­ne­ously. This ad­vance­ment al­lows re­searchers to an­a­lyse cell much more care­fully and it gives them a bet­ter in­sight of the cell.

Se­condly, clin­i­cal es­tab­lish­ments are us­ing this tech­nol­ogy in­creas­ingly. Ear­lier this was driven by the re­searchers who were fo­cused on find­ing in­sights of the cells. Now, es­tab­lish­ments are us­ing these in­sights to un­der­stand even the clin­i­cal as­pects. As flow cy­tom­e­try pro­vides faster and ac­cu­rate results, it is get­ting used par­tic­u­larly in on­col­ogy for leukaemia, lym­phoma, MRD (Min­i­mum Resid­ual Dis­ease) HIV and other dis­eases as well. There­fore clin­i­cal es­tab­lish­ments like hos­pi­tals and lab­o­ra­tory chains are pro­gres­sively us­ing this tech­nol­ogy. This brings us to im­por­tant con­sid­er­a­tions like ease of use and the smaller foot­print of the in­stru­ment as im­por­tant fac­tor to­wards a faster adop­tion. So tech­nolo­gies that are ad­vanced, eas­ier to use are pre­ferred to­day. In­stru­ments are be­com­ing smaller, mak­ing them more por­ta­ble and eas­ier to main­tain. In­dian health­care en­vi­ron­ment is gain­ing mo­men­tum and is be­ing fu­elled by an ex­pan­sion of lab­o­ra­tory chains. I strongly believe that the market is ex­pand­ing and so is the com­pe­ti­tion.

What are ma­jor chal­lenges be­fore bio­sup­pli­ers in­dus­try? Sug­ges­tions to over­come these is­sues?

One of the chal­lenges is abil­ity to use these tech­nolo­gies in mul­ti­ple ap­pli­ca­tions. One must have clar­ity to put this ap­pli­ca­tion to ap­pro­pri­ate use and to as­sist re­searchers and clin­i­cians nav­i­gate through this, ap­pli­ca­tion spe­cial­ists know­ing the tech­nol­ogy and its ap­pli­ca­tion be­come more rel­e­vant. It is im­por­tant to train and sup­port the users of this tech­nol­ogy with its ap­pli­ca­tions and mostly com­pa­nies are fail­ing to do so.

At BD, our team of trained ap­pli­ca­tion spe­cial­ists, mostly post-grad­u­ates and Ph.Ds in Bio­sciences are able to de­ci­pher the needs of the cus­tomers and ac­cord­ingly ad­vise and sup­port them in de­vel­op­ing dif­fer­ent ap­pli­ca­tions.

Ad­di­tion­ally these ma­chines are very high­tech. They re­quire a pre­cise way of us­age, stor­age and han­dling and not many users may be trained that might re­sult in fre­quent break-downs or un­sat­is­fac­tory out­comes.

Ge­o­graphic spread of In­dia poses a big chal­lenge be­cause com­pa­nies have only a fi­nite num­ber of ser­vice en­gi­neers and since the tech­nol­ogy is ever evolv­ing, not ev­ery en­gi­neer is trained on the ad­vanced model of each prod­uct. It is crit­i­cal to de­ter­mine the ef­fec­tive op­ti­mi­sa­tion of ex­ist­ing re­sources keep­ing both cus­tomer ex­pec­ta­tions and ge­o­graphic lay­out in mind.

How do you see the op­por­tu­ni­ties for bio­sup­pli­ers?

With rapidly grow­ing health­care sec­tor, this do­main of­fers sig­nif­i­cant op­por­tu­ni­ties for many play­ers. One of the big­gest and dom­i­nant buy­ers of this tech­nol­ogy un­doubt­edly is the Gov­ern­ment of In­dia funded or­gan­i­sa­tions such as CSIR, ICMR, DBT, in­sti­tutes of higher ed­u­ca­tion like IITs and IISERs.

I am very op­ti­mistic that the cur­rent is en­cour­ag­ing the sci­en­tists to work to­wards pro­duc­ing the out­comes of re­search; as to how it will cre­ate a so­cial im­pact and ul­ti­mately ad­vance the world of health and well-be­ing i.e trans­la­tional re­search. I also an­tic­i­pate in­creased fo­cus on med­i­cal re­search ar­eas for cancer, HIV in the near fu­ture.

Murli Sun­drani

Busi­ness Di­rec­tor, BD Life Sci­ences-Bio­sciences

« Murli Sun­drani Busi­ness Di­rec­tor, BD Life Sci­ences-Bio­sciences

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.